The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Onychomycosis-Global Market Insights and Sales Trends 2024
Synopsis
Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails to be affected. Complications may include cellulitis of the lower leg.
The global Onychomycosis market size is expected to reach US$ 14900 million by 2029, growing at a CAGR of 6.3% from 2023 to 2029. The market is mainly driven by the significant applications of Onychomycosis in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Others,, are propelling Onychomycosis market. Distal Subungual Onychomycosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the White Superficial Onychomycosis segment is estimated at % CAGR for the next seven-year period.
Onychomycosis occurs in about 10 percent of the adult population. Older people are more frequently affected. Males are affected more often than females. Onychomycosis represents about half of nail disease.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Onychomycosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Onychomycosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Onychomycosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Onychomycosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Onychomycosis covered in this report include Abbott Laboratories, Glaxosmithkline, Pfizer, Bausch Health, Galderma, Janssen Biotech, Bristol Meyer Squibb, Topica Pharmaceuticals and Sanofi, etc.
The global Onychomycosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Glaxosmithkline
Pfizer
Bausch Health
Galderma
Janssen Biotech
Bristol Meyer Squibb
Topica Pharmaceuticals
Sanofi
Novartis
Global Onychomycosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Onychomycosis market, Segment by Type:
Distal Subungual Onychomycosis
White Superficial Onychomycosis
Proximal Subungual Onychomycosis
Candida Onychomycosis
Others
Global Onychomycosis market, by Application
Hospital Pharmacies
Retail Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Onychomycosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails to be affected. Complications may include cellulitis of the lower leg.
The global Onychomycosis market size is expected to reach US$ 14900 million by 2029, growing at a CAGR of 6.3% from 2023 to 2029. The market is mainly driven by the significant applications of Onychomycosis in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Others,, are propelling Onychomycosis market. Distal Subungual Onychomycosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the White Superficial Onychomycosis segment is estimated at % CAGR for the next seven-year period.
Onychomycosis occurs in about 10 percent of the adult population. Older people are more frequently affected. Males are affected more often than females. Onychomycosis represents about half of nail disease.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Onychomycosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Onychomycosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Onychomycosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Onychomycosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Onychomycosis covered in this report include Abbott Laboratories, Glaxosmithkline, Pfizer, Bausch Health, Galderma, Janssen Biotech, Bristol Meyer Squibb, Topica Pharmaceuticals and Sanofi, etc.
The global Onychomycosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Glaxosmithkline
Pfizer
Bausch Health
Galderma
Janssen Biotech
Bristol Meyer Squibb
Topica Pharmaceuticals
Sanofi
Novartis
Global Onychomycosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Onychomycosis market, Segment by Type:
Distal Subungual Onychomycosis
White Superficial Onychomycosis
Proximal Subungual Onychomycosis
Candida Onychomycosis
Others
Global Onychomycosis market, by Application
Hospital Pharmacies
Retail Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Onychomycosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Onychomycosis
1.1 Onychomycosis Market Overview
1.1.1 Onychomycosis Product Scope
1.1.2 Onychomycosis Market Status and Outlook
1.2 Global Onychomycosis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Onychomycosis Market Size by Region (2018-2029)
1.4 Global Onychomycosis Historic Market Size by Region (2018-2023)
1.5 Global Onychomycosis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Onychomycosis Market Size (2018-2029)
1.6.1 North America Onychomycosis Market Size (2018-2029)
1.6.2 Europe Onychomycosis Market Size (2018-2029)
1.6.3 Asia-Pacific Onychomycosis Market Size (2018-2029)
1.6.4 Latin America Onychomycosis Market Size (2018-2029)
1.6.5 Middle East & Africa Onychomycosis Market Size (2018-2029)
2 Onychomycosis Market by Type
2.1 Introduction
2.1.1 Distal Subungual Onychomycosis
2.1.2 White Superficial Onychomycosis
2.1.3 Proximal Subungual Onychomycosis
2.1.4 Candida Onychomycosis
2.1.5 Others
2.2 Global Onychomycosis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Onychomycosis Historic Market Size by Type (2018-2023)
2.2.2 Global Onychomycosis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Onychomycosis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Onychomycosis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Onychomycosis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Onychomycosis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Onychomycosis Revenue Breakdown by Type (2018-2029)
3 Onychomycosis Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Others
3.2 Global Onychomycosis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Onychomycosis Historic Market Size by Application (2018-2023)
3.2.2 Global Onychomycosis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Onychomycosis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Onychomycosis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Onychomycosis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Onychomycosis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Onychomycosis Revenue Breakdown by Application (2018-2029)
4 Onychomycosis Competition Analysis by Players
4.1 Global Onychomycosis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Onychomycosis as of 2022)
4.3 Date of Key Players Enter into Onychomycosis Market
4.4 Global Top Players Onychomycosis Headquarters and Area Served
4.5 Key Players Onychomycosis Product Solution and Service
4.6 Competitive Status
4.6.1 Onychomycosis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Onychomycosis Products, Services and Solutions
5.1.4 Abbott Laboratories Onychomycosis Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Glaxosmithkline
5.2.1 Glaxosmithkline Profile
5.2.2 Glaxosmithkline Main Business
5.2.3 Glaxosmithkline Onychomycosis Products, Services and Solutions
5.2.4 Glaxosmithkline Onychomycosis Revenue (US$ Million) & (2018-2023)
5.2.5 Glaxosmithkline Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Onychomycosis Products, Services and Solutions
5.3.4 Pfizer Onychomycosis Revenue (US$ Million) & (2018-2023)
5.3.5 Bausch Health Recent Developments
5.4 Bausch Health
5.4.1 Bausch Health Profile
5.4.2 Bausch Health Main Business
5.4.3 Bausch Health Onychomycosis Products, Services and Solutions
5.4.4 Bausch Health Onychomycosis Revenue (US$ Million) & (2018-2023)
5.4.5 Bausch Health Recent Developments
5.5 Galderma
5.5.1 Galderma Profile
5.5.2 Galderma Main Business
5.5.3 Galderma Onychomycosis Products, Services and Solutions
5.5.4 Galderma Onychomycosis Revenue (US$ Million) & (2018-2023)
5.5.5 Galderma Recent Developments
5.6 Janssen Biotech
5.6.1 Janssen Biotech Profile
5.6.2 Janssen Biotech Main Business
5.6.3 Janssen Biotech Onychomycosis Products, Services and Solutions
5.6.4 Janssen Biotech Onychomycosis Revenue (US$ Million) & (2018-2023)
5.6.5 Janssen Biotech Recent Developments
5.7 Bristol Meyer Squibb
5.7.1 Bristol Meyer Squibb Profile
5.7.2 Bristol Meyer Squibb Main Business
5.7.3 Bristol Meyer Squibb Onychomycosis Products, Services and Solutions
5.7.4 Bristol Meyer Squibb Onychomycosis Revenue (US$ Million) & (2018-2023)
5.7.5 Bristol Meyer Squibb Recent Developments
5.8 Topica Pharmaceuticals
5.8.1 Topica Pharmaceuticals Profile
5.8.2 Topica Pharmaceuticals Main Business
5.8.3 Topica Pharmaceuticals Onychomycosis Products, Services and Solutions
5.8.4 Topica Pharmaceuticals Onychomycosis Revenue (US$ Million) & (2018-2023)
5.8.5 Topica Pharmaceuticals Recent Developments
5.9 Sanofi
5.9.1 Sanofi Profile
5.9.2 Sanofi Main Business
5.9.3 Sanofi Onychomycosis Products, Services and Solutions
5.9.4 Sanofi Onychomycosis Revenue (US$ Million) & (2018-2023)
5.9.5 Sanofi Recent Developments
5.10 Novartis
5.10.1 Novartis Profile
5.10.2 Novartis Main Business
5.10.3 Novartis Onychomycosis Products, Services and Solutions
5.10.4 Novartis Onychomycosis Revenue (US$ Million) & (2018-2023)
5.10.5 Novartis Recent Developments
6 North America
6.1 North America Onychomycosis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Onychomycosis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Onychomycosis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Onychomycosis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Onychomycosis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Onychomycosis Market Dynamics
11.1 Onychomycosis Industry Trends
11.2 Onychomycosis Market Drivers
11.3 Onychomycosis Market Challenges
11.4 Onychomycosis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
